【其他高分选 091】

PMID:39869305

IF:10.4

Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer

PMID:39868848

IF:14.3

Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP

PMID:39868462

IF:15.5

Breast Cancer-Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood-Brain Barrier Endothelial Cells

PMID:39879120

IF:12.5

Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection that Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe

PMID:39879115

IF:12.5

Breaking the Rhythm: Harnessing the Menstrual Cycle for Better Chemotherapy

PMID:39879109

IF:12.5

Genomic Analysis Reveals Racial and Age-Related Differences in the Somatic Landscape of Breast Cancer and the Association with Socioeconomic Factors

PMID:39880556

IF:56.7

Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial

PMID:39888288

IF:14.3

Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer

PMID:39887132

IF:15.8

Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade

PMID:39885132

IF:14.7

Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer

PMID:39891928

IF:12.5

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

PMID:39892389

IF:11.1

Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures

PMID:39890808

IF:14.7

Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism

PMID:39903832

IF:12.5

Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer Progression

PMID:39903522

IF:12.5

Multiparametric MRI and transfer learning for predicting positive margins in breast-conserving surgery: a multi-center study

PMID:39903070

IF:12.1

Using AI to Select Women with Intermediate Breast Cancer Risk for Breast Screening with MRI

PMID:39864590

IF:11.4

FOXS1, frequently inactivated by promoter methylation, inhibited colorectal cancer cell growth by promoting TGFBI degradation through autophagy-lysosome pathway

PMID:39870803

IF:13.7

Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway

PMID:39870395

IF:23.1

Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) T cells

PMID:39870220

IF:26.3

Enhancing Colorectal Cancer Subtyping: Addressing Limitations of L1-Penalized Estimation in Alternative Splicing Analysis

PMID:39879477

IF:10.4

Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas

PMID:39879113

IF:12.5

An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer

PMID:39877288

IF:10.7

Salt-inducible kinase 2 confers radioresistance in colorectal cancer by facilitating homologous recombination repair

PMID:39876002

IF:11.4

E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration

PMID:39875519

IF:13.7

YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer

PMID:39879477

IF:10.4

Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas

PMID:39888380

IF:16.4

IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategies

PMID:39888307

IF:14.3

Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer

PMID:39895630

IF:13.3

HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis

PMID:39895631

IF:13.3

HMGA1 is a crucial mediator of colon tumorigenesis driven by the loss of APC

PMID:39898465

IF:15.8

Functional Nanosheet Immunoswitches Reprogramming Innate Macrophages for Immunotherapy of Colorectal Cancer and Sepsis

PMID:39903759

IF:14.3

Chromosome Missegregation Triggers Tumor Cell Pyroptosis and Enhances Anti-Tumor Immunotherapy in Colorectal Cancer

PMID:39903566

IF:12.5

Development and prospects of natural orifice specimen extraction surgery for colorectal cancer: a review article

PMID:39866701

IF:13.1

A Pair of Fluorescent Probes Enabling Precise Diagnosis of Liver Cancer by Complementary Imaging

PMID:39874200

IF:14.3

Oral Microalgae-Based Biosystem to Enhance Irreversible Electroporation Immunotherapy in Hepatocellular Carcinoma

PMID:39871338

IF:27.7

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis

PMID:39871325

IF:16.7

MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

PMID:39871237

IF:10.6

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS

PMID:39870619

IF:13.0

Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma

PMID:39876004

IF:27.7

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARalpha-mediated fatty acid oxidation

PMID:39878177

IF:12.5

Construction of an Artificially Intelligent Model for Accurate Detection of HCC by Integrating Clinical, Radiological, and Peripheral Immunological Features

PMID:39881544

IF:12.1

Centrosome protein TAX1BP mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in Hepatocellular Carcinoma

PMID:39887258

IF:13.0

Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets

PMID:39892819

IF:26.8

Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity

PMID:39889705

IF:48.8

Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer

PMID:39899759

IF:13.0

Beyond monotherapy: Combining radiotherapy with sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus

PMID:39899681

IF:14.3

Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis

PMID:39897540

IF:12.4

Betaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM/m(6)A/YTHDF1-mediated enhancement on ATG3 stability

PMID:39899681

IF:14.3

Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis

PMID:39903758

IF:14.3

RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol-Triggered MET Activation

PMID:39871783

IF:10.7

Nanomedicine in Immunotherapy for Non-Small Cell Lung Cancer: Applications and Perspectives

PMID:39873606